Abstract: A process and system for effective treatment of a water stream containing dissolved metal contaminants. The process and system employ the electrocoagulation principle to enable precipitation of the dissolved metal contaminants and provide sufficient residence time for completion of the precipitation process so that flocs of the dissolved metal contaminants that can be easily separated are generated thereby resulting in effective treatment of the water stream.

Abstract: Technologies for providing enhanced management of processing errors include a compute device. The compute device includes circuitry configured to obtain error data indicative of errors resulting from integration of a component configured to add functionality to a data processing system of an institution. The compute device is also configured to perform statistical analysis on the obtained error data to produce error analytics data and produce a visual representation indicative of the error analytics data to enable efficient remediation of the errors.

Abstract: The present invention relates to triterpene glycoside saponin-derived adjuvants, syntheses thereof, intermediates thereto, and uses thereof. QS-7 is a potent immuno-adjuvant that is significantly less toxic than QS-21, a related saponin that is currently the favored adjuvant in anticancer and antiviral vaccines. Tedious isolation and purification protocols have hindered the clinical development of QS-7. A novel semi-synthetic method is provided wherein a hydrolyzed prosapogenin mixture is used to synthesize QS-7, QS-21, and related analogs, greatly facilitating access to QS-7 and QS-21 analogs for preclinical and clinical evaluation.

Abstract: A system for assaying a biological sample for a presence of a target analyte includes an assaying device and a computer controller. The assaying device includes a housing, a receptacle disposed in the housing, and a source of activation energy. The receptacle is configured to accept an electrophoresis cell. The electrophoresis cell has a recess area configured to accept a chip configured to accept the biological sample. The chip includes a polymeric separation medium with activatable functional groups that covalently bond to the target analyte when activated. The source of activation energy is configured to supply activation energy to activate the activatable functional groups. The computer controller is operably coupled to the source of activation energy and is configured to activate the source of activation energy to direct an application of activation energy to the polymeric separation medium to activate the activatable functional groups.

Abstract: Method and apparatus for a pest control device mounting system configured for mounting pest control devices in a building and using them to control pests. The pest control device mounting system including a mounting bracket, which may have a circumferential portion defining a portal. In some examples, the mounting bracket includes a flange portion suitable for attaching to the perimeter of a cavity in a building surface. The pest control device mounting system including a plug configured to be removably attached to the mounting bracket and to substantially close the portal when attached to the mounting bracket, wherein the plug is configured to accommodate a pest control device.

Abstract: The introduction of electronics into a drug delivery device may introduce certain technical challenges, such as durability, electro-mechanical integration, and drug delivery performance. The present disclosure provides solutions for inclusion of an electronics module with an inhaler. For example, heat stakes may be used to secure a printed circuit board (PCB) to an electronics module's housing. Also for example, a slider may be used to transfer vertical movement of an inhaler's yoke to an electronics module's switch. Also for example, certain seals may be used when interfacing the electronics module to other portions of the device's housing to achieve a desired performance.

Abstract: The present invention concerns a vehicle management system for controlling movement of a plurality of vehicles along a pathway at a current geographic location of a transport network, the vehicle management system comprising: a receiver configured to: receive sensed kinematic parameters of the plurality of vehicles at the current geographic location; and receive event data relating to the occurrence of an event concerning the movement of the plurality of vehicles, a processor configured to: determine required kinematic parameters of at least one of the plurality of vehicles in order to respond to the event; determine, based on the sensed kinematic parameters and the required kinematic parameters, one or more actions to be taken by the one or more of the plurality of vehicles which enable the required kinematic parameters to be achieved; and generate one or more instruction signals for the one or more vehicles to instruct the one or more actions to be taken; and a transmitter configured to transmit the one or

Abstract: The present invention concerns a vehicle tracking device for tracking one or more vehicles at a geographic location of a ransport network within which the one or more vehicles are able to move, the vehicle tracking device comprising: one or more infra-red (IR) sensors having a field of view and being configured to detect IR radiation being emitted from or reflected by the one or more vehicles at the geographic location within the field of view; a receiver configured to receive unique identification data which uniquely identifies each of the one or more vehicles and position data which indicates an initial position of each of the one or more vehicles when the one or more vehicles enter the field of view at the geographic location; a processor configured to determine current kinematic data of the one or more vehicles in at least two dimensions based upon the IR radiation detected by the one or more IR sensors, the received unique identification data and the received position data; and a transmitter configured t

Abstract: A computer implemented method of controlling an interactive hybrid environment representing a motorised sporting event at a track is described. The interactive hybrid environment includes representations of real and virtual vehicles on the track.

Abstract: An embryo, gamete or stem cell culture medium comprising: a) acetyl-carnitine at a concentration of about 5 to about 50 ?M; and b) lipoic acid or a derivative thereof at a concentration of about 2.5 to about 40 ?M. The culture medium may optionally further comprises acetyl-cysteine at a concentration of about 5 to about 50 ?M.

Abstract: A debris collection device for collecting and transporting debris includes a shell, which defines an interior space. The shell is flexible and thus collapsible. The shell has a top, which is open for insertion of articles, such as debris, into the interior space. A pair of sleeves is engaged singly to and extends along opposed sides of the shell proximate to the top. Each of a pair of poles is selectively insertable into a respective sleeve so that opposed terminal sections of the pole protrude from the sleeve. The opposed terminal sections can be grasped in hands of user, positioning the user to lift the shell and the articles.

Abstract: The introduction of electronics into a drug delivery device may introduce certain technical challenges, such as durability, electro-mechanical integration, and drug delivery performance. The present disclosure provides solutions for inclusion of an electronics module with an inhaler. For example, heat stakes may be used to secure a printed circuit board (PCB) to an electronics module's housing. Also for example, a slider may be used to transfer vertical movement of an inhaler's yoke to an electronics module's switch. Also for example, certain seals may be used when interfacing the electronics module to other portions of the device's housing to achieve a desired performance.

Abstract: The introduction of electronics into a drug delivery device may introduce certain technical challenges, such as durability, electro-mechanical integration, and drug delivery performance. The present disclosure provides solutions for inclusion of an electronics module with an inhaler. For example, heat stakes may be used to secure a printed circuit board (PCB) to an electronics module's housing. Also for example, a slider may be used to transfer vertical movement of an inhaler's yoke to an electronics module's switch. Also for example, certain seals may be used when interfacing the electronics module to other portions of the device's housing to achieve a desired performance.

Abstract: In some embodiments, the present disclosure is directed to a method that comprises: (a) identifying and storing dedicated preferred access agreements between application service providers and telecommunication service providers; (b) capturing and analyzing application service provider subscriber usage for defined service applications; and (c) automating purchase or removal of telecommunication service provider features for identified subscribers based on the preferred access agreements and the analyzing of the application service provider subscriber usage.

Abstract: In some embodiments, a method includes producing, from an adapter, a first wireless signal characterized by a first communication mode with a computing device when a portion of at least one of a medicament delivery device or a simulated medicament delivery is disposed within the adapter. An indication is received when the portion of the medicament delivery device or the simulated medicament delivery device is removed from the adapter. A second wireless signal characterized by a second communication mode with the computing device is produced in response to the indication. The second communication mode is different from the first communication mode. The second communication mode can be, for example, a hold mode, a sniff mode or a park mode.

Abstract: A method may include initiating a static analysis of code including a first function, detecting, in the first function and by the static analysis, an indirect call to a second function whose identity is unknown until the code is executed, detecting, in the code, a conditional block including a first instruction sequence and a second instruction sequence, determining, by the static analysis, that the first instruction sequence sets a value that identifies the second function, and adding the value to a called function list for the code.

Abstract: The present invention provides a method for diagnosing in a subject Acute Kidney Injury or a related or analogous disease state. The method comprises the steps of a) providing a sample taken from the subject: b) analysing the sample from the subject to determine the level of a biomarker selected from certain atomic species; and c) comparing the level of the biomarker in the sample to a reference level of the biomarker that is characteristic of a healthy subject, eg a subject having normal renal function. An elevated level of the biomarker in the sample relative to the reference level is indicative of Acute Kidney Injury or a related or analogous disease state. The invention also relates to the use of an atomic species selected from those in Table 1 as a biomarker for Acute Kidney Injury or a related or analogous disease state, and test kits comprising an analytical element sensitive to those biomarkers.

Abstract: A method may include initiating a static analysis of code including a first function, detecting, in the first function and by the static analysis, an indirect call to a second function whose identity is unknown until the code is executed, detecting, in the code, a conditional block including a first instruction sequence and a second instruction sequence, determining, by the static analysis, that the first instruction sequence sets a value that identifies the second function, and adding the value to a called function list for the code.

Abstract: In some embodiments, the present disclosure is directed to a method that comprises: (a) identifying and storing dedicated preferred access agreements between application service providers and telecommunication service providers; (b) capturing and analyzing application service provider subscriber usage for defined service applications; and (c) automating purchase or removal of telecommunication service provider features for identified subscribers based on the preferred access agreements and the analyzing of the application service provider subscriber usage.

Abstract: Systems and methods for mobile device usage optimization are described herein. These methods can include automated mobile device usage data collection, analysis, usage optimization through device level pooling, reallocation, and/or other device plan optimizations.